Hola,
Are you new here?

CARE

financed

COMMON ACTION AGAINST HIV TB HCV ACROSS THE REGIONS OF EUROPE

CARE brings together distinguished scientists and highly representative networks in the European region, including Russia, in the fight against HIV/TB/HCV. CARE research objectives are based on already established European cohort... see more

30/06/2021

EuResist

3M€

Project Budget: 3M€

Project leader

EURESIST NETWORK GEIE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

PARTICIPATION DEPralty Sin fecha límite de participación.

Ver 17 Participantes

Financing granted El organismo H2020 notifico la concesión del proyecto The day 2021-06-30

SC1-BHC-21-2018: Research on HIV, tuberculosis (TB)... Specific Challenge:ECDC (European Centre for Disease Control) and WHO-Europe (World Health Organisat...

I+D

Cerrada does 7 years

0% 91% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

17 Participantes

EuResist

378.50K€ | Leader

FZB

252.50K€ | participant

KLINIKUM DER UNIVERSITAET ZU...

150.00K€ | participant

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project duration: 31 months Date Start: 2018-11-21
End date: 2021-06-30

Project leader

EURESIST NETWORK GEIE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Project Budget 3M€

participation deadline Sin fecha límite de participación.

Project description CARE brings together distinguished scientists and highly representative networks in the European region, including Russia, in the fight against HIV/TB/HCV. CARE research objectives are based on already established European cohort networks with extensive and longitudinal data and/or sample collections. Together with new data and sample collections and cohorts created during the project, CARE will produce high-level researchoutputs during the two years of the project timeframe. The specific short term objectives are to: ● Discover and validate novel soluble biomarkers of MDR-TB treatment success and of pulmonary TB. ● Explore host genetic mechanisms of susceptibility to extrapulmonary TB. ● Analyse genotype to phenotype correlations in MDR-TB and develop a decision making support tool. ● Define epidemiology and pathways of drug-resistant HIV, including their relationship with HIV subtypes and TB coinfection to support an evidence-based introduction of INSTIs as part of first line antiretroviral therapy. ● Discover and validate host genomic variants influencing susceptibility to contracting AIDS and serious non-AIDS clinical events and adverse reactions to drugs. ● Derive best practice recommendations for DAA prioritisation strategies for HCV treatment. The longer-term objective of CARE is to implement a research infrastructure that allows the expansion of activities beyond the funding frame, permitting the partners to share technology, protocols, structured data collections and knowledge. Finally, CARE activities include realization of recommendations and intervention plans, communication to the stakeholders, dissemination and training activities in order to develop and distribute the highest expertise and competence throughout the European region for the containment of the epidemics.CARE is fully in line with the call topic and addresses all its subtopics. It involves a recognised Russian partner coordinating 5 top level institutions covering the regions of Russia.

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers